You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 2, February 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  STUDIES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (20)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clinical and Histologic Heterogeneity of Psoriatic Plaques

Therapeutic Relevance

Thomas D. Griffin, MD; Anand Lattanand, MD; Eugene J. VanScott, MD

Arch Dermatol. 1988;124(2):216-220.


Abstract

• Twenty-three patients with resistant psoriasis vulgaris were evaluated clinically and histologically before and after treatment with potent topically administered steroids. It was shown that psoriatic plaques are comprised of clinically and histologically distinct acute and chronic areas, each responding differently to treatment. Chronic areas, characterized by chronic inflammation, respond well to therapy; acute areas, characterized by acute inflammation, are resistant to therapy. It is suggested that the psoriagenic stimulus is greater within the therapy-resistant "hot spots." Future therapy aimed at hot spots may aid in the better control of psoriasis.

(Arch Dermatol 1988;124:216-220)



Author Affiliations

From the Skin and Cancer Hospital, Temple University Health Sciences Center, Philadelphia.


Footnotes

Accepted for publication Sept 17,1987.

Presented as a poster at the 45th annual meeting of the American Academy of Dermatology, New Orleans, Dec 6-11, 1986.

Reprint requests to Skin and Cancer Hospital, Temple University Health Sciences Center, 3322 N Broad St, Philadelphia, PA 19140 (Dr Griffin).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Quantification of Chemotactic Peptides (C5a Anaphylatoxin and IL-8) in Psoriatic Lesional Skin
Takematsu and Tagami
Arch Dermatol 1993;129:74-80.
ABSTRACT  

Sulfasalazine Improves Psoriasis: A Double-blind Analysis
Gupta et al.
Arch Dermatol 1990;126:487-493.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.